Anti-TB drug information sheets

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014.

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

Show details

Contents

< Prev Next >

PART 3Anti-TB drug information sheets

Adapted from Tuberculosis Drug Information Guide. 2nd Edition. California: Curry International Tuberculosis Center and California Department of Public Health; 2012, except where otherwise referenced.

Common presentations of the drugs are described; actual preparations may vary depending on the manufacturer.

Amikacin (Amk) (PDF, 243K)

Amoxicillin/Clavulanate (Amx/Clv) (PDF, 54K)

Bedaquiline² (Bdq) (PDF, 59K)

Capreomycin (Cm) (PDF, 136K)

Clarithromycin (Clr) (PDF, 135K)

Clofazimine (Cfz) (PDF, 60K)

Cycloserine (Cs) [and Terizidone (Trd)] (PDF, 62K)

Ethambutol (Emb) (PDF, 56K)

Ethionamide (Eto)/Protionamide (Pto) (PDF, 56K)

Gatifloxacin (Gfx) (PDF, 56K)

Imipenem (Imp)/Cilastatin (Cln) (PDF, 62K)

Isoniazid (Inh) (PDF, 56K)

Kanamycin (Km) (PDF, 63K)

Levofloxacin (Lfx) (PDF, 86K)

Linezolid (Lzd) (PDF, 56K)

Meropenem (Mpm) (PDF, 56K)

Moxifloxacin (Mfx) (PDF, 55K)

Para-aminosalicyclic acid (PAS) (PDF, 85K)

Pyrazinamide (Pza) (PDF, 62K)

Rifabutin (Rfb) (PDF, 56K)

Rifampin (Rif) (PDF, 56K)

Rifapentine (Rpt) (PDF, 56K)

Streptomycin (Sm) (PDF, 63K)

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution–should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK247415

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014. PART 3, Anti-TB drug information sheets.
PDF version of this title (2.2M)

Other titles in this collection

WHO Guidelines Approved by the Guidelines Review Committee

Recent Activity

Clear Turn Off Turn On

Anti-TB drug information sheets - Companion Handbook to the WHO Guidelines for t...
Anti-TB drug information sheets - Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis
Streptomyces griseus gene for 16S ribosomal RNA, complete sequence
Streptomyces griseus gene for 16S ribosomal RNA, complete sequence
gi|971126|dbj|D63872.1|
Nucleotide
RecName: Full=BPI fold-containing family A member 1; AltName: Full=Lung-specific...
RecName: Full=BPI fold-containing family A member 1; AltName: Full=Lung-specific protein X; AltName: Full=Nasopharyngeal carcinoma-related protein; AltName: Full=Palate lung and nasal epithelium clone protein; AltName: Full=Secretory protein in upper respiratory tracts; AltName: Full=Short PLUNC1; Short=SPLUNC1; AltName: Full=Tracheal epithelium-enriched protein; AltName: Full=Von Ebner protein Hl; Flags: Precursor
gi|17380173|sp|Q9NP55.1|BPIA1_HUMAN
Protein
LOC4339648 [Oryza sativa Japonica Group]
LOC4339648 [Oryza sativa Japonica Group]
Gene ID:4339648
Gene
LOC4327388 [Oryza sativa Japonica Group]
LOC4327388 [Oryza sativa Japonica Group]
Gene ID:4327388
Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

PART 3Anti-TB drug information sheets

Views

Other titles in this collection

Recent Activity